Top

G-Rex500M Bioreactors

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The National Institutes of Health Clinical Center, specifically the Center for Cellular Engineering, is seeking to acquire five cases of G-Rex500M-CS bioreactors and associated freight. The current contract, valued at 38,378.20 dollars, is held by Wilson Wolf Manufacturing, LLC under a firm fixed price arrangement. This requirement is categorized under NAICS code 339113 for Surgical Appliance and Supplies Manufacturing and is expected to reach a potential end date on September 18, 2026. The procurement is currently positioned as a sole source award because these specific bioreactors are validated and approved by the CCE Quality Assurance Department for FDA-regulated manufacturing processes in cell-based therapies. Substituting the manufacturer would risk delaying manufacturing schedules and impacting patient care due to the need for extensive re-validation. While the government intends to proceed with Wilson Wolf Manufacturing, interested sources may submit capability statements by August 7, 2026, to demonstrate their ability to provide an equivalent product without requiring additional validation.

General Info

NIH awarded Wilson Wolf Manufacturing $38,378.20 for five G-Rex500M-CS bioreactors via sole source.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedMar 18

pre-forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

Shasheshe Goolsby

contact@example.gov

+1 (555) 000-0000

Full Description

Predicted recompete opportunity based on federal award data.
Current Contract: 75N98026P01357 Incumbent: WILSON WOLF MANUFACTURING, LLC Contract Value: $38,378.2 Potential End Date: 2026-09-18T00:00:00.000Z Competition: COMPETED UNDER SAP Pricing: FIRM FIXED PRICE Classification: recompete-likely (Confidence: medium - 55/100)

Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), Clinical Center

Office: Center for Cellular Engineering (CCE)

Title: G-Rex500M Bioreactors

NAICS Code: 339113 – Surgical Appliance and Supplies Manufacturing

PSC Code: 6530 – Hospital Furniture, Equipment, Utensils, and Supplies

Authority: FAR 13.106-1(b)(1), Only One Source Reasonably Available (Simplified Acquisition Threshold)

Description

The National Institutes of Health (NIH), Clinical Center, Center for Cellular Engineering (CCE) intends to award a sole source purchase order to Wilson Wolf Manufacturing for the acquisition of five (5) cases of G‑Rex500M-CS (2-pack box) bioreactors and associated freight.

Justification

CCE uses G‑Rex500M bioreactors in validated FDA-regulated manufacturing processes for cell-based therapies supporting NIH clinical trials. These bioreactors have been validated and approved by the CCE Quality Assurance Department. Substituting another manufacturer's product would require extensive qualification and validation testing, increase costs, delay manufacturing schedules, and could adversely impact the timely treatment of critically ill patients. Wilson Wolf Manufacturing is the only known source capable of providing the validated G‑Rex500M bioreactors that meet the Government's requirements.

Interested Sources

This is not a request for competitive quotations. However, any responsible source that believes it can provide an equivalent product meeting all of the Government's technical and quality requirements may submit a capability statement with supporting documentation demonstrating its ability to satisfy the requirement without additional validation or interruption to patient care.

Capability statements should include:

Legal business name, address, Unique Entity ID, CAGE code, and point-of-contact information.

Business size under NAICS 339113 and applicable socioeconomic status.

Relevant past performance information for comparable requirements.

Responses must reference Notice ID 26-008050 and be submitted electronically no later than August 7, 2026, at 11:00 a.m. Eastern Time. Telephone inquiries will not be accepted.:

Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division
Office of Acquisitions and Logistics Management
National Institutes of Health
Email: contact@example.gov

The Government will evaluate all capability statements received. However, the determination not to compete this requirement remains solely within the Government's discretion.

Disclaimer

If no affirmative written responses are received by the closing date, the Government intends to proceed with a sole source award to Wilson Wolf Manufacturing.